Ibex Medical Analytics pioneers AI-based cancer diagnostics in pathology.
Pathologists are challenged to provide accurate and timely cancer diagnoses as their workloads keep increasing due to a rise in cancer prevalence and advances in personalized medicine that result in growing diagnostic complexity.
Ibex uses AI to help pathologists, hospitals and healthcare providers improve the quality of cancer diagnoses, lab efficiencies and health economics by enhancing diagnostic accuracy, implementing real-time quality control and reducing turnaround times and operating costs.
Ibex’s AI-powered Galen™ platform demonstrated outstanding outcomes in multi-site, independent clinical studies. Galen is deployed at pathology institutes worldwide and used in routine practice, with demonstrated success in improving diagnostic quality, detecting missed cancer cases and enhancing productivity and efficiency.
